Brief: Collegium Announces Authorized Agreement With Hikma Pharmaceuticals USA For Nucynta
29/04/2024 13:02
April 29 (Reuters) - Collegium Pharmaceutical Inc
COLL.O :
* COLLEGIUM ANNOUNCES AUTHORIZED GENERIC AGREEMENT WITH
HIKMA
PHARMACEUTICALS USA INC. FOR NUCYNTA® AND NUCYNTA® ER
* COLLEGIUM: HIKMA WILL HAVE EXCLUSIVE RIGHT TO SELL
AUTHORIZED
GENERIC VERSIONS OF NUCYNTA & NUCYNTA ER IN U.S.
Source text for Eikon: ID:nGNX7yGX8W
Further company coverage: COLL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Collegium Pharmaceutical
See all newsBrief: Collegium Pharmaceutical - Co And Grünenthal Enter Settlement Agreement On Oct 15, 2026 - SEC Filing
Brief: Collegium Announces $50 Million Accelerated Share Repurchase Program
U.S. RESEARCH ROUNDUP-Airbnb, Expedia Group, Parker-Hannifin
Collegium Pharmaceutical Inc reports results for the quarter ended June 30 - Earnings Summary
Collegium Q2 revenue rises 6%